Myth: Naloxone provides a safety net to active users, encourages or increases drug use, and sends the wrong message.
Fact: Just like seat belts and speed limits do not encourage dangerous driving, providing access to naloxone to people at risk of overdose does not encourage or increase drug use. Studies report that naloxone does not encourage drug use, and in fact, has been shown to decrease it in some circumstances and increase individuals’ desire to seek drug treatment. Naloxone also causes unpleasant withdrawal symptoms in people dependent on opioids, an experience no one who uses opioids aims to achieve.
Myth: Naloxone access will replace calling 911.
Fact: Overdose prevention programs teach people to call 911, even if naloxone has already been administered. Naloxone only lasts 30-90 minutes, and once it wears off, individuals can be at risk of overdose again. There may also be other medical conditions occurring that require medical attention.
Myth: Naloxone will prevent people who use drugs from seeking treatment.
Fact: Death prevents people from seeking treatment. Naloxone keeps people alive long enough and provides people with additional chances to receive treatment. Every life is worth saving, every time.
Myth: A person under the influence of drugs cannot be trusted to respond appropriately to an overdose.
Fact: Community members, including people who use drugs, can be easily trained in overdose recognition/response. Since 1996, over 150,000 community members have been trained on naloxone and over 26,000 overdose reversals have taken place using naloxone. The vast majority of these overdose reversals occurred in the community by people who use drugs.
Myth: Naloxone makes people violent.
Fact: While it has happened that when someone is revived with naloxone they are in “flight or flight response”, this is not a common occurrence when compared to the tens of thousands of overdose reversals that have taken place. This can be a concern if someone was administered too much naloxone, meaning more than was necessary to reverse the overdose. When administering naloxone, especially high-dose products that cannot be titrated, it is critical to wait a few minutes in between doses.
Become a DCF Naloxone Provider
Florida Department of Children and Families (DCF) Overdose Prevention Program (OPP)
The Florida Department of Children and Families (DCF) Overdose Prevention Program (OPP) is designed to reduce opioid overdose deaths by providing access to FDA-approved emergency opioid antagonists, as defined in s. 381.887(1)(d), F.S., to organizations that serve individuals at risk of witnessing or experiencing an opioid overdose. NARCAN Nasal Spray is the emergency opioid antagonist DCF currently purchases and makes available to eligible organizations. The OPP has 2 primary goals:
Provide overdose recognition and response training to organizations and individuals who may witness or experience an opioid overdose; and
Distribute free naloxone kits to individuals at risk of experiencing an opioid overdose, as well as to friends and family members who may witness an opioid overdose.
Eligible organizations include non-profits that hand out free take-home naloxone kits directly to individuals at risk of experiencing an opioid overdose, and to friends and family who may witness an overdose.
Due to limited funding, DCF naloxone kits are only to be handed out to people at risk of experiencing an overdose and their friends/family who may witness an overdose. As such, DCF naloxone kits are not available for law enforcement departments, EMS agencies, or fire departments. However, if law enforcement departments and EMS agencies want to start a naloxone “leave behind” program, where free naloxone kits would be left at the scene of an overdose with friends/family of the overdose victim, they may be eligible to receive DCF naloxone for this purpose.
DCF Contact Information
To request a training, or to enroll in DCF’s Overdose Prevention Program, contact: